Daniel Lookadoo
Chief Scientific Officer, StataDX
2026 REU Project: Coming Soon
StataDX aims to build the first point-of-care diagnostic platform for Neurology– a “liquid MRI for the brain.” The company’s technology supports multi-biomarker guided disease management strategies both in clinical settings and at home using a simple finger-prick blood sample.
Previous REU/RET Projects Include:
- Advancing Early Alzheimer’s Detection with Biosensing (REU, 2025)
- Magnetic Force-Assisted Biosensor (REU, 2023)
- Electrochemical Biosensing of Neurofilaments (RET, 2023)
- Multi-Electrode Chip Prototype for Electrochemical Biosensing (REU/RET, 2022)
- Fluorescent Imaging Prototype for Paper-based Diagnostics (REU/RET, 2021)
- Departments
- Biomedical Engineering and Mechanical Engineering
- Affiliation
- Business Innovation Center
- Program Year
- 2021, 2022, 2023, and 2025